5.80M
Market cap
Current P/E
Forward P/E

About

Health care
Sector
Biotechnology
Industry

Helix BioMedix, Inc. operates as a specialty dermatology and consumer products skin health company in the United States. It develops and commercializes bioactive peptides, including anti-infective, anti-fungal, and anti-inflammatory peptides for the treatment of skin and wound infections, as well as for the prevention of staphylococcus aureus infections. The company also out-licenses its proprietary peptides to various entities.

Similar securities

Based on sector and market capitalization

Report issue